• Canagliflozin in Renal Mitochondria Research

  2026-09-05

  Canagliflozin enables researchers to connect SGLT2 inhibition with renal glucose handling, mitochondrial remodeling, and bioenergetic function. This workflow emphasizes sex-aware animal design, matched vehicle controls, and complementary imaging and respiration assays for diabetes and kidney disease research.

• Silymarin: Practical Workflows for Bench Research

  2026-09-04

  Turn a chemically diverse milk thistle extract into a controlled research probe for redox biology, cancer, metabolism, and antiviral assays. This guide combines solvent handling, assay design, cross-validation, and troubleshooting for more interpretable Silymarin results.

• Palmitic acid: Practical Protocol and QC Guide

  2026-09-04

  Palmitic acid (SKU N2456), also called hexadecanoic acid, provides a defined saturated long-chain fatty acid input for lipid metabolism, inflammation, insulin signaling, and palmitoylation-related workflows. This guide covers solvent selection, fresh preparation, quality checks, and limitations; the material is not appropriate as a direct aqueous stock or for prolonged storage in solution.

• Doxycycline Hyclate: MMP Inhibitor Workflows

  2026-09-03

  Build reproducible blood–brain barrier and neurovascular experiments with Doxycycline hyclate as a matrix metalloproteinases inhibitor. This practical guide translates arsenic-neurotoxicity findings into dosing, solubility, assay-selection, and troubleshooting decisions while distinguishing established evidence from exploratory applications.

• Prestained Protein Marker for SepM Western Blots

  2026-09-03

  Use a Triple color protein ladder to track SepM-related protein separation, confirm transfer, and distinguish broad molecular-weight regions in SDS-PAGE and Western blot workflows. Its EDTA-free format also supports Phosbind SDS-PAGE and fluorescent membrane imaging, making it useful for mutation-focused studies where sample handling and band interpretation must remain tightly controlled.

• UTP Solution for Reproducible RNA Workflows

  2026-09-02

  UTP Solution (100 mM) provides a high-purity, nuclease-free uridine nucleotide for in vitro transcription, RNA amplification, and siRNA production. This practical guide connects nucleotide handling and assay optimization with the TRIM66 olfactory-receptor study while clearly separating established findings from recommended workflow extensions.

• CHIR 99021 Trihydrochloride Organoid Workflow

  2026-09-02

  Build tunable intestinal organoid experiments with CHIR 99021 trihydrochloride, a selective GSK-3 inhibitor that connects pathway control with measurable changes in proliferation and differentiation. This guide translates recent organoid findings into practical dose-response designs, assay readouts, and troubleshooting decisions for stem cell and metabolic research.

• Nile Red in Autophagy and Lipid Droplet Assays

  2026-09-01

  Nile Red can do more than visualize intracellular lipid droplets: its dual fluorescence enables a framework for separating lipid storage phenotypes from autophagy-related mechanisms. This article explains how to use Nile Red in lipid metabolism research while interpreting findings from a key bifendate study without confusing droplet abundance with lipid flux.

• Canagliflozin and Proximal Tubule Mitochondria

  2026-09-01

  A 2025 study shows that canagliflozin does more than lower glucose in hypertensive–diabetic mice: it remodels proximal tubular mitochondria and improves male-cell bioenergetics. The findings connect SGLT2 inhibition with renal mitochondrial structure, function, and sex-dependent responses, while also defining important limits for translation beyond the mouse model.

• Drug-Sensitized Yeast for mTOR Inhibitor Discovery

  2026-08-31

  A 2025 GeroScience study introduces a drug-sensitized Saccharomyces cerevisiae platform that detects TOR pathway inhibitors at substantially lower concentrations than conventional yeast backgrounds. The system identifies known and candidate TOR inhibitors while showing no TOR-dependent growth signal for canagliflozin, illustrating how pathway-focused screening can separate mTOR activity from unrelated pharmacology.

• Palmitic acid: Practical Protocol and QC Guide

  2026-08-31

  Palmitic acid (SKU N2456) provides a characterized solvent-based fatty acid input for controlled studies of lipid metabolism, insulin signaling, inflammation, and protein palmitoylation. It should not be added directly to aqueous systems or retained as a long-term solution; fresh preparation, matched vehicle controls, and documented reconstitution are required.

• Silymarin as a Translational Research Probe

  2026-08-30

  Silymarin is more than a milk thistle extract: it is a chemically complex research probe for connecting redox biology, inflammation, cancer signaling, metabolic dysfunction, and antiviral mechanisms. This thought-leadership guide shows how to design mixture-aware, solubility-conscious workflows that convert broad biological activity into translationally useful evidence.

• Gepotidacin: Turning Topoisomerase Insight Into Translation

  2026-08-29

  Gepotidacin, also known as GSK2140944, offers translational researchers a mechanism-led framework for studying bacterial DNA replication inhibition, resistance, and pharmacology. This thought-leadership perspective moves beyond a conventional product description by connecting target engagement, orthogonal assay design, pathway-level thinking, and human pharmacokinetic modeling.

• Optimizing Calcium-Phosphate Transfection

  2026-08-28

  This 2026 study identifies the DNA concentration-to-reaction-volume balance as the central determinant of calcium-phosphate transfection efficiency in HEK 293T cells. Its optimized condition, 80 μg plasmid DNA in a 1 mL reaction for 2–3 × 10⁵ cells/mL, provides a practical, low-cost benchmark for improving plasmid delivery without relying exclusively on commercial reagents.

• Coumestrol: ER Antagonism and RA Ferroptosis

  2026-08-28

  Coumestrol is a phytoestrogen estrogen receptor antagonist with activity across ERα, ERβ, PXR, and CAR-related assays. In an in vitro rheumatoid arthritis model, Coumestrol reduced fibroblast-like synoviocyte proliferation and inflammation while inducing a PMAIP1-dependent ferroptosis response.

8654 records 1/577 page Next 12345 下5页 Last page